Drugmakers Mallinckrodt, Endo in talks to merge, Bloomberg News reports
12/03/2025 18:31
March 12 (Reuters) - Mallinckrodt Pharmaceuticals MCKPF.PK and Endo NDOI.PK are exploring a potential merger that could be valued at about $7 billion, Bloomberg News reported on Wednesday, citing people with knowledge of the matter. (Reporting by Bhanvi Satija in Bengaluru; Editing by Arun Koyyur) ((Bhanvi.Satija@thomsonreuters.com; Outside U.S. +91 9873062788;))
Recent news on Endo
See all newsBrief: Mallinckrodt, Endo Announce Planned Leadership Team For Merged Company
Brief: Endo To Report First Quarter 2025 Financial Results On May 7, 2025
Deals of the day-Mergers and acquisitions
Corrected: Deals of the day-Mergers and acquisitions
To Pay Endo $80.2 Million Termination Fee If Deal Is Terminated Under Certain Conditions